1. Role of immune escape in different digestive tumours
   Xin-Zhu Du et al, 2021, World Journal of Clinical Cases CrossRef
2. Cancer evolution: A means by which tumors evade treatment
   Xiao Zhu et al, 2021, Biomedicine & Pharmacotherapy CrossRef
3. Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
   Yuqing Cao et al, 2020, Signal Transduction and Targeted Therapy CrossRef
4. Understanding cell‐cell communication and signaling in the colorectal cancer microenvironment
   Shaikha AlMusawi et al, 2021, Clinical and Translational Medicine CrossRef
5. High PD-L1 expression predicts poor prognosis in diffuse large B-cell lymphoma
   Zhiheng Cheng et al, 2018, Annals of Hematology CrossRef
6. LPS promotes the expression of PD‐L1 in gastric cancer cells through NF‐κB activation
   Hui Li et al, 2018, Journal of Cellular Biochemistry CrossRef
7. Monospecific and Polyreactive Monoclonal Antibodies against Human Leukocyte Antigen-E: Diagnostic and Therapeutic Relevance
   Mepur H. Ravindranath et al, 2021, Monoclonal Antibodies CrossRef
8. Natural killer cells as a promising therapeutic target for cancer immunotherapy
   Nayoung Kim et al, 2019, Archives of Pharmacal Research CrossRef
9. Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
   Mepur H. Ravindranath et al, 2023, Biomolecules CrossRef
10. Extracellular vesicles-derived microRNA-222 promotes immune escape via interacting with ATF3 to regulate AKT1 transcription in colorectal cancer
    Shiquan Li et al, 2021, BMC Cancer CrossRef
11. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
    Nayoung Kim et al, 2018, Frontiers in Immunology CrossRef
12. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
    Tristan Courau et al, 2019, Journal for ImmunoTherapy of Cancer CrossRef
13. Control of NK Cell Activation by Immune Checkpoint Molecules
    Asma Beldi-Ferchiou et al, 2017, International Journal of Molecular Sciences CrossRef
14. HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival
    Zhifeng Wu et al, 2020, BMC Neurology CrossRef
15. Therapeutic vaccines for colorectal cancer: The progress and future prospect
    Mina Shahnazari et al, 2020, International Immunopharmacology CrossRef
16. Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors
    Barbara Seliger, 2017, Cytokine & Growth Factor Reviews CrossRef
17. Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
    Ziqing Chen et al, 2019, Cancers CrossRef
18. Dimorphism of HLA-E and its Disease Association
    Leonid Kanevskiy et al, 2019, International Journal of Molecular Sciences CrossRef
19. Enhancing Natural Killer and CD8+T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8+T Cells with HLA-E Monospecific Monoclonal Antibodies
    Mepur H. Ravindranath et al, 2019, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef